$2.73
Evaxion Biotech is a biotechnology business based in the US. Evaxion Biotech shares (EVAX) are listed on the NASDAQ and all prices are listed in US Dollars. Evaxion Biotech employs 49 staff and has a trailing 12-month revenue of around $124,000.
Our top picks for where to buy Evaxion Biotech AS stock
How to buy Evaxion Biotech stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – EVAX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Evaxion Biotech stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Evaxion Biotech stock price (NASDAQ: EVAX)
Use our graph to track the performance of EVAX stocks over time.Evaxion Biotech shares at a glance
Latest market close | $2.75 |
---|---|
52-week range | $2.26 - $13.82 |
50-day moving average | $3.29 |
200-day moving average | $5.16 |
Wall St. target price | $11.75 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-5.40 |
Is it a good time to buy Evaxion Biotech stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Evaxion Biotech price performance over time
Historical closes compared with the close of $2.7454 from 2024-07-23
1 week (2024-07-17) | -5.00% |
---|---|
1 month (2024-06-24) | 2.06% |
3 months (2024-04-24) | -33.53% |
6 months (2024-01-24) | -74.22% |
1 year (2023-07-24) | 117.89% |
---|---|
2 years (2022-07-22) | 6.41% |
3 years (2021-07-23) | 5.35 |
5 years (2019-07-20) | N/A |
Evaxion Biotech financials
Revenue TTM | $124,000 |
---|---|
Gross profit TTM | $0 |
Return on assets TTM | -79.47% |
Return on equity TTM | -269.37% |
Profit margin | 0% |
Book value | $0.56 |
Market Capitalization | $15.2 million |
TTM: trailing 12 months
Evaxion Biotech share dividends
We're not expecting Evaxion Biotech to pay a dividend over the next 12 months.
Have Evaxion Biotech's shares ever split?
Evaxion Biotech's shares were split on a 1:10 basis on 21 January 2024. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Evaxion Biotech shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Evaxion Biotech shares which in turn could have impacted Evaxion Biotech's share price.
Evaxion Biotech share price volatility
Over the last 12 months, Evaxion Biotech's shares have ranged in value from as little as $2.26 up to $13.82. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Evaxion Biotech's is -0.274. This would suggest that Evaxion Biotech's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Evaxion Biotech has bucked the trend.
To put Evaxion Biotech's beta into context you can compare it against those of similar companies.
- Aeglea Bio Therapeutics (AGLE.US): 2.572
- XBiotech (XBIT.US): 1.381
- Geron Corporation (GERN.US): 0.477
Evaxion Biotech overview
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase 1/2a trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy that is in pre-clinical stage for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. Evaxion Biotech A/S was incorporated in 2008 and is based in Horsholm, Denmark. .
Frequently asked questions
nullWhat percentage of Evaxion Biotech is owned by insiders or institutions?
Currently 16.6% of Evaxion Biotech shares are held by insiders and 7.383% by institutions. How many people work for Evaxion Biotech?
Latest data suggests 49 work at Evaxion Biotech. When does the fiscal year end for Evaxion Biotech?
Evaxion Biotech's fiscal year ends in December. Where is Evaxion Biotech based?
Evaxion Biotech's address is: Dr. Neergaards Vej, Horsholm, Denmark, 2970 What is Evaxion Biotech's ISIN number?
Evaxion Biotech's international securities identification number is: US29970R1059
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
How to buy the new spot Ethereum ETFs
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 top semiconductor stocks to buy in 2024
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
-
11 best brokerage accounts of July 2024: Top picks for investors
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
Ask a question